Boris Kovačic

2.1k total citations
25 papers, 1.4k citations indexed

About

Boris Kovačic is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Boris Kovačic has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Boris Kovačic's work include Cytokine Signaling Pathways and Interactions (11 papers), Immune Cell Function and Interaction (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Boris Kovačic is often cited by papers focused on Cytokine Signaling Pathways and Interactions (11 papers), Immune Cell Function and Interaction (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Boris Kovačic collaborates with scholars based in Austria, United States and Germany. Boris Kovačic's co-authors include Richard Moriggl, Hartmut Beug, Veronika Sexl, Marc A. Kerenyi, Andrea Hoelbl‐Kovacic, Florian Grebien, Wolfgang Warsch, Lothar Hennighausen, Dagmar Stoiber and Eva Weisz and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Boris Kovačic

24 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Kovačic Austria 17 692 463 461 389 354 25 1.4k
Bradley W. Blaser United States 20 630 0.9× 816 1.8× 613 1.3× 945 2.4× 299 0.8× 46 2.1k
Margarete Zaborski Germany 20 306 0.4× 660 1.4× 608 1.3× 302 0.8× 346 1.0× 43 1.5k
Yosuke Minami Japan 22 395 0.6× 802 1.7× 812 1.8× 287 0.7× 355 1.0× 103 1.6k
Erik A. Nelson United States 23 887 1.3× 907 2.0× 530 1.1× 869 2.2× 299 0.8× 38 2.3k
Steffen Klippel United States 15 363 0.5× 686 1.5× 611 1.3× 146 0.4× 326 0.9× 27 1.2k
Seiichi Okabe Japan 18 273 0.4× 404 0.9× 417 0.9× 170 0.4× 287 0.8× 92 969
Carmela Gurrieri Italy 18 393 0.6× 915 2.0× 360 0.8× 353 0.9× 304 0.9× 46 1.5k
Simone Boehrer Germany 24 367 0.5× 1.0k 2.2× 620 1.3× 243 0.6× 415 1.2× 68 1.7k
Yutaka Okuno Japan 22 391 0.6× 1.2k 2.5× 694 1.5× 511 1.3× 132 0.4× 66 1.9k

Countries citing papers authored by Boris Kovačic

Since Specialization
Citations

This map shows the geographic impact of Boris Kovačic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Kovačic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Kovačic more than expected).

Fields of papers citing papers by Boris Kovačic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Kovačic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Kovačic. The network helps show where Boris Kovačic may publish in the future.

Co-authorship network of co-authors of Boris Kovačic

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Kovačic. A scholar is included among the top collaborators of Boris Kovačic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Kovačic. Boris Kovačic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Salzer, Benjamin, Charlotte U. Zajc, Timo Peters, et al.. (2020). Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function. Nature Communications. 11(1). 4166–4166. 68 indexed citations
3.
Kovačic, Boris, Margit Rosner, Karin Schlangen, Nina Kramer, & Markus Hengstschläger. (2019). DRUGPATH – a novel bioinformatic approach identifies DNA-damage pathway as a regulator of size maintenance in human ESCs and iPSCs. Scientific Reports. 9(1). 1897–1897. 5 indexed citations
4.
Kramer, Nina, Margit Rosner, Boris Kovačic, & Markus Hengstschläger. (2016). Full biological characterization of human pluripotent stem cells will open the door to translational research. Archives of Toxicology. 90(9). 2173–2186. 6 indexed citations
5.
Schipany, Katharina, et al.. (2015). eIF3 controls cell size independently of S6K1-activity. Oncotarget. 6(27). 24361–24375. 11 indexed citations
6.
Kovačic, Boris, et al.. (2015). Clinical impact of studying epithelial–mesenchymal plasticity in pluripotent stem cells. European Journal of Clinical Investigation. 45(4). 415–422. 2 indexed citations
7.
Kovačic, Boris, Andrea Hoelbl‐Kovacic, Katrin Fischhuber, et al.. (2014). Lactotransferrin-Cre reporter mice trace neutrophils, monocytes/macrophages and distinct subtypes of dendritic cells. Haematologica. 99(6). 1006–1015. 16 indexed citations
8.
Rütgen, Barbara C., Saskia Willenbrock, Ingrid Walter, et al.. (2012). Authentication of Primordial Characteristics of the CLBL-1 Cell Line Prove the Integrity of a Canine B-Cell Lymphoma in a Murine In Vivo Model. PLoS ONE. 7(6). e40078–e40078. 19 indexed citations
9.
Grebien, Florian, Oliver Hantschel, John Wojcik, et al.. (2011). Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis. Cell. 147(2). 306–319. 107 indexed citations
10.
Hoelbl‐Kovacic, Andrea, Christian Schuster, Boris Kovačic, et al.. (2010). Stat5 is indispensable for the maintenance of bcr/abl ‐positive leukaemia. EMBO Molecular Medicine. 2(3). 98–110. 185 indexed citations
11.
Friedbichler, Katrin, Marc A. Kerenyi, Boris Kovačic, et al.. (2010). Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation. Blood. 116(9). 1548–1558. 48 indexed citations
12.
Grebien, Florian, Marc A. Kerenyi, Boris Kovačic, et al.. (2008). Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. Blood. 111(9). 4511–4522. 81 indexed citations
13.
Schuster, Christian, Boris Kovačic, Sabine Fajmann, et al.. (2008). Evaluation of Stat5 as a potential drug target in bcr/abl-induced leukemias. BMC Pharmacology. 8(S1). 1 indexed citations
14.
Moriggl, Richard, Florian Corvinus, Bernd Wiederanders, et al.. (2007). Signal Transducer and Activator of Transcription 3 Activation Promotes Invasive Growth of Colon Carcinomas through Matrix Metal loproteinase Induction. Neoplasia. 9(4). 279–291. 121 indexed citations
15.
Hoelbl‐Kovacic, Andrea, Boris Kovačic, Marc A. Kerenyi, et al.. (2006). Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood. 107(12). 4898–4906. 168 indexed citations
16.
Kovačic, Boris, Dagmar Stoiber, Richard Moriggl, et al.. (2006). STAT1 acts as a tumor promoter for leukemia development. Cancer Cell. 10(1). 77–87. 127 indexed citations
17.
Höeller, Christoph, Barbara Pratscher, Christiane Thallinger, et al.. (2005). Clusterin Regulates Drug-Resistance in Melanoma Cells. Journal of Investigative Dermatology. 124(6). 1300–1307. 41 indexed citations
18.
Stoiber, Dagmar, Boris Kovačic, Christian Schuster, et al.. (2004). TYK2 is a key regulator of the surveillance of B lymphoid tumors. Journal of Clinical Investigation. 114(11). 1650–1658. 52 indexed citations
19.
Stoiber, Dagmar, Boris Kovačic, Christian Schuster, et al.. (2004). TYK2 is a key regulator of the surveillance of B lymphoid tumors. Journal of Clinical Investigation. 114(11). 1650–1658. 52 indexed citations
20.
Sexl, Veronika, Boris Kovačic, Roland P. Piekorz, et al.. (2003). Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Blood. 101(12). 4937–4943. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bradley W. Blaser Breakdown of academic impact, for papers by Margarete Zaborski Breakdown of academic impact, for papers by Yosuke Minami Breakdown of academic impact, for papers by Erik A. Nelson Breakdown of academic impact, for papers by Steffen Klippel Breakdown of academic impact, for papers by Seiichi Okabe Breakdown of academic impact, for papers by Carmela Gurrieri Breakdown of academic impact, for papers by Simone Boehrer Breakdown of academic impact, for papers by Yutaka Okuno
Rankless by CCL
2026